A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/10/2004	EP1474428A1 Crystalline hydrochloride of 7- [(5-amino-1,2,4-thiadiazol-3-yl)(fluoromethoxyimino)acetyl]amino -3-[(imino-1-piperazinylmethyl)methylhydrazono]-methyl-3-cephem-4-carboxylic acid
11/10/2004	EP1474427A1 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474424A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
11/10/2004	EP1474423A1 Heterocyclic tripeptides as hepatitis c inhibitors
11/10/2004	EP1474422A1 R− (−) −1− 2− &lpar ;7−CHLOROBENZO i b /i THIOPHEN−3 &minus ;YL− METHOXY) −2− (2,4−DICHLOROPHENYL) −ETHYL −1 i H /i −IMID AZOLE
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474420A1 Quinazoline compounds
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474416A1 Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
11/10/2004	EP1474415A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
11/10/2004	EP1474414A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
11/10/2004	EP1474413A2 Novel decalactones from associated fungi of marine sponges and their synthetic derivatives as medicaments
11/10/2004	EP1474412A2 Production of delta-9 tetrahydrocannabinol
11/10/2004	EP1474408A1 N-phenyl-2-pyrimidine-amine derivatives
11/10/2004	EP1474405A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474402A1 Salts of valsartan
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474400A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)] -6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1474398A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
11/10/2004	EP1474397A1 Therapeutic acridone and acridine compounds
11/10/2004	EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474394A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
11/10/2004	EP1474393A1 Aryl ureas as kinase inhibitors
11/10/2004	EP1474392A1 Polymorphic form xvi of fexofenadine hydrochloride
11/10/2004	EP1474391A1 Water soluble phenylglycine derivatives
11/10/2004	EP1474387A2 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation
11/10/2004	EP1474385A1 Urea linker derivatives for use as ppar modulators
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1474175A2 Agents that regulate apoptosis
11/10/2004	EP1474174A1 Composition for oral or rectal administration
11/10/2004	EP1474172A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/10/2004	EP1474171A1 Weight management system for obese animals
11/10/2004	EP1474169A2 Means and methods for altering the motility of the gastrointestinal tract
11/10/2004	EP1474162A1 Methods and compositions for the treatment of eye diseases
11/10/2004	EP1474158A2 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
11/10/2004	EP1474155A1 Method of treatment of gastrointestinal disease and polymeric composition for use therein
11/10/2004	EP1474154A2 Improvements in or relating to compositions
11/10/2004	EP1474153A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
11/10/2004	EP1474152A1 Orodispersible pharmaceutical composition comprising ivabradine
11/10/2004	EP1474151A2 Methods of treatment of chronic immune disease
11/10/2004	EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones
11/10/2004	EP1474149A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
11/10/2004	EP1474148A1 Treatment of neuroblastoma
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474146A1 Phenylpyrimidine amines as ige inhibitors
11/10/2004	EP1474145A1 Quinoline derivatives as npy antagonists
11/10/2004	EP1474144A1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
11/10/2004	EP1474143A2 Methods and compositions for treating male erectile dysfunction
11/10/2004	EP1474142A2 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
11/10/2004	EP1474141A1 5-ht2b receptor antagonists
11/10/2004	EP1474140A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	EP1474138A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474136A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474134A1 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
11/10/2004	EP1474133A2 Crystalline solids of carvedilol and processes for their preparation
11/10/2004	EP1474132A1 Histamine-3 receptor ligands for diabetic conditions
11/10/2004	EP1474131A1 Use of anethole dithiolethione in lung cancer chemoprevention
11/10/2004	EP1474130A2 Use of compounds and compositions derived from olives for protecting cells against dna damage
11/10/2004	EP1474129A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
11/10/2004	EP1474128A2 S−DIMETHYLARSINO−THIOSUCCINIC ACID S−DIMETHYLARSINO−2−THIOBENZOIC ACID S−(DIMETHYLARSINO) GLUTATHIONE AS TREATMENTS FOR CANCER
11/10/2004	EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents
11/10/2004	EP1474126A2 Treatments for neurotoxicity in alzheimer's disease
11/10/2004	EP1474125A1 The use of omega-3 polyunsaturated acids ethyl esters in patients suffering from heart failure
11/10/2004	EP1474124A1 Active ingredient for producing a substance containing isocitrate for influencing the coagulation tendency of blood
11/10/2004	EP1474123A1 Controlled release pharmaceutical formulation containing venlafaxine
11/10/2004	EP1474122A2 Compounds for blocking androgen receptors
11/10/2004	EP1474121A2 Small molecule antagonists of bcl2 family proteins
11/10/2004	EP1474119A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
11/10/2004	EP1474118A1 Composition for inhalation
11/10/2004	EP1474117A1 Composition for inhalation
11/10/2004	EP1474116A1 Colonic release composition
11/10/2004	EP1474114A1 Oral dosage form for controlled drug release
11/10/2004	EP1474112A1 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
11/10/2004	EP1474111A1 Sterile lyophilized ifosfamide and associated methods
11/10/2004	EP1474109A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2004	EP1474108A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
11/10/2004	EP1474103A1 Levothyroxine compositions and methods
11/10/2004	EP1474101A1 Anti-microbial composition comprising a metal ion chelating agent
11/10/2004	EP1474085A2 In situ bonds
11/10/2004	EP1474069A1 Control of a biological function
11/10/2004	EP1473996A1 Formulations comprising triazoles and alkoxylated amines
11/10/2004	EP1416799A4 Methods and compositions for treating fungal infections
11/10/2004	EP1370560B1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
11/10/2004	EP1296682A4 Chemosensitizer
11/10/2004	EP1280803B1 Crystalline form ii of cabergoline
11/10/2004	EP1267897B1 Treatment of congestive heart failure by pretreated autologous blood
11/10/2004	EP1265880B1 Method for the preparation of citalopram
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1259515B1 Thienopyridine derivatives and their use as anti-inflammatory agents
11/10/2004	EP1251847A4 Novel use of prodigiosin for treating diabetes mellitus
11/10/2004	EP1248833A4 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition
11/10/2004	EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/10/2004	EP1240172B1 New aminopropylphosphinic acids
11/10/2004	EP1237562B1 Process for preparing mikania extracts containing mikanolide and dihydromikanolide and use in the treatment of proliferative disorders

1 ... 4897 4898 4899 4900 4901 4902 4903 4904 4905 4906 4907 4908 4909 4910 4911 4912 4913 4914 4915 4916 4917 ... 7860